Related Experiment Video
Updated: Mar 26, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Changes in Postpartum Insulin Requirements for Patients with Well-Controlled Type 1 Diabetes
Hilary A Roeder1, Thomas R Moore1, Gladys A Ramos1
1Division of Perinatology, Department of Reproductive Medicine, UC San Diego Health, San Diego, California.
Insights
Postpartum insulin needs for women with type 1 diabetes mellitus (T1DM) significantly decrease compared to preconception levels. Infant feeding method and insulin delivery type did not impact these reduced postpartum insulin doses.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Maternal-Fetal Medicine
Background:
- Type 1 diabetes mellitus (T1DM) requires careful insulin management throughout pregnancy.
- Postpartum metabolic changes can significantly alter insulin requirements in women with T1DM.
- Understanding postpartum insulin needs is crucial for safe and effective diabetes management after delivery.
Purpose of the Study:
- To compare preconception and postpartum total daily insulin (TDI) doses in well-controlled T1DM.
- To investigate the influence of infant feeding methods on postpartum insulin requirements.
- To assess differences in postpartum insulin dosing based on insulin administration route (CSII vs. MDI).
Main Methods:
- Retrospective cohort study of 44 women with T1DM and HbA1c ≤ 7.4%.
- Comparison of preconception and postpartum total daily insulin (TDI) doses.
- Abstraction of data on insulin administration method, HbA1c, BMI, and infant feeding practices.
Main Results:
- A significant 34% decrease in postpartum TDI compared to preconception TDI was observed (p=0.02).
- No significant differences in postpartum TDI were found between breastfed and formula-fed infants.
- Insulin administration route (CSII vs. MDI) did not impact postpartum TDI.
Conclusions:
- Women with T1DM require substantially less insulin postpartum compared to preconception.
- Postpartum insulin dosage adjustments are necessary and appear independent of infant feeding method or insulin delivery system.
- These findings support a re-evaluation of postpartum insulin dosing strategies in T1DM patients.
Abstract:
Objective To compare postpartum with preconception insulin doses in well-controlled (HbA1c ≤ 7.4%) type 1 diabetes mellitus (T1DM) and to characterize differences in postpartum insulin dosing based on infant feeding. Study Design The primary outcome in this retrospective cohort was the change in total daily insulin (TDI) from preconception to postpartum. Insulin administration (continuous subcutaneous insulin infusion [CSII] vs. multiple daily injections [MDI]), HbA1c, body mass index (BMI), and infant feeding were abstracted. Results We identified 44 women with T1DM and HbA1c ≤ 7.4%. Preconception mean BMI was 24.6 ± 3.6 kg/m(2) and median (interquartile range [IQR]) HbA1c was 6.4 (6.0-6.9)%. Of these, 73% used CSII and 27% used MDI. Additionally, 80% of patients reported exclusive breastfeeding, 7% were exclusively formula feeding, and 13% used both breast milk and formula. Median (IQR) preconception TDI was 0.64 (0.49-0.69) U/kg/day, and postpartum: 0.39 (0.30-0.50) U/kg/day. Postpartum TDI was 34% lower than preconception TDI (p = 0.02). There was no difference in the postpartum TDI in patients who were breast versus formula feeding or when comparing CSII with MDI. Conclusion There was a significant decrease in the TDI required postpartum when compared with preconception. Dosages do not seem to be impacted by administration route or breastfeeding. These findings warrant consideration when dosing postpartum insulin in patients with T1DM.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

